November 19, 2021
Biolinq’s wearable glucose monitoring patch incorporates a microarray of independent electrochemical biosensors.
Stories this photo appears in:
HEALTHCARE: San Diego Co. Unveils Painless Glucose Sensor Patch
Biolinq, a medical device company developing a continuous glucose sensor with a novel integrated display on its wearable device, has closed a $100 million Series B financing round led by RiverVest Venture Partners.